Clonidine Interactions with Modafinil and Bupropion

Metabolism and Pharmacokinetics

Clonidine undergoes hepatic metabolism but is not primarily dependent on CYP2D6 or CYP3A4 pathways that are commonly involved in drug-drug interactions, with approximately 40-60% of clonidine excreted unchanged in urine, reducing its vulnerability to metabolic drug interactions 1
The American College of Cardiology notes that clonidine's metabolism is not significantly impacted by modafinil or bupropion through direct pharmacokinetic pathways 1

The American Academy of Child and Adolescent Psychiatry guidelines state that there are no studies of the combination of bupropion and stimulants, but note the PDR does not warn against interactions between bupropion and other medications in ADHD treatment contexts 2, 3
Clonidine does not rely on CYP2D6 for its metabolism, making pharmacokinetic interactions with bupropion unlikely, as bupropion is metabolized primarily through CYP2B6 to its active metabolite 4-hydroxybupropion and acts as a potent inhibitor of CYP2D6 1

Modafinil acts as a moderate inducer of CYP3A4 and P-glycoprotein, but since clonidine is not primarily metabolized through CYP3A4 and has significant renal excretion, modafinil's induction effects are unlikely to meaningfully reduce clonidine plasma concentrations 1, 4
The American College of Cardiology recommends monitoring for additive cardiovascular effects, including blood pressure changes and heart rate alterations, when combining clonidine with modafinil 4

Monitor for potential antagonism of clonidine's hypotensive effects, as both medications can affect cardiovascular parameters, with bupropion increasing norepinephrine activity and clonidine being an alpha-2 agonist that typically lowers blood pressure 1, 4
Measure blood pressure and heart rate at baseline and regularly during treatment, as clonidine causes hypotension and bradycardia while modafinil and bupropion can cause cardiovascular stimulation 1, 2, 4
Never abruptly discontinue clonidine, as this can precipitate hypertensive crisis; always taper to avoid rebound hypertension, according to the American College of Cardiology 1